Prof. Jacques Pouyssegur

• born in Toulouse, France in 1943
• 1966 Engineer in Biochemistry, INSA (University of Lyon)
• 1971 Doctor-Engineer (Thesis) INSA (University of Lyon)
• 1972 Doctor es-Sciences (Thesis) INSA (University of Lyon)
• 1968-1971 Assistant and Attaché de Recherche CNRS
• 1972 University of Leicester, Laboratory of Biochemistry (Pr. Hans Kornberg), England
• 1973 University of Lyon, Virology Unit, INSERM (Dr.J. Huppert), France, post-doc fellow
• 1974-1976 National Cancer Institute, NIH, Bethesda, USA, Laboratory of Molecular Biology (Dr. Ira Pastan), post-doc fellow
• 1989 University of San Francisco, Laboratory of Prof. Henri Bourne, 1989, Sabbatical
• 1996 Whitehead Institute, Cambridge USA, Laboratory of Dr. Robert Weinberg, sabbatical
• 1980-present Directeur de Recherche CNRS, Head of a research group on the control of cell division,
• 1977-present Director of the Institute of Signaling, Developmental Biology and Cancer Research

Specialization

• main field : Growth control - Signal transduction - MAP kinases - Molecular bases of angiogenesis - Hypoxia signaling
• previous interests : (1) Glucose Transport, Glycolysis and Cancer (2) Thrombin receptor signaling - (3) Na-H co-transporters and growth control

Major prestigious awards

• British Council Award (1972), National Institute of Health Award (1974-76), Short term EMBO
• Savoie Prize (Ligue Nationale Française contre le Cancer) (1989),
• Delahautemaison Prize of Nephrology (Fondation pour la Recherche Medicale) (1989),
• Rosen Prize of oncology (Fondation pour la Recherche Médicale) (1995),
• Lounsbery Prize 1996 (French and American Academy of Sciences),
• Athena-Institut de France Prize (1999)
• Leopold Griffuel Prize (Association for Cancer research) (2001).

Author and co-author of nearly 300 papers in refereed journals (incl. Circulation, J. Cell Physiol., JBC, EMBO J., Eur. J. Biocem., Curr. Pharm. Des., Mol. Cell. Boil., Oncogene, Biocem. Pharmaco., PNAS), 70 book chapters, and 290 lectures to scientific meetings as invited speaker.

 

 

Prof. Andreas Bikfalvi

• born Budapest, Hungary in 1955
• 1983 Medical Degree (MD): University of Brittany (Brest, France)
• 1989 Philosophical Degree (PhD): University Paris VII
• 1994 "Habilitation ŕ diriger la Recherche" (HDR), University Paris XII
• 1983-1986 Resident: Haematology-Oncology, University Kiel (Pr. H. Loeffler) Germany
• 1986-1989 PhD training and research: Unit INSERM 150 (Pr JP Caen), Paris (Director : Pr. G. Tobelem)
• 1989-1991 Post-doctoral fellow: INSERM Unit 118, Paris
  (Director : Dr Yves Courtois)
• 1991-1995 Post-doctoral fellow: New York University Medical Centre, Department of Cell Biology, Pr. D.B. Rifkin's Laboratory
• 1995 Researcher at CNRS unit 12 18 (Director: Pr.D. Barritault)
• 1995 - present Professor (full Professor, tenure) in Cell and Molecular Biology, University Bordeaux I, Head of the Growth Factor and Cell Differentiation Laboratory (now:Molecular Angiogenesis Laboratory, INSERM EMI 0113)
• 2001 - present first class full Professor ("Professeur premiere classe) upon decision of the National Board of the French Universities ("Commission Nationale Universitaire", CNU).

Research Interests
Angiogenesis, growth factor biology, cancer, vascular cell biology

He is currently the head of the Molecular Angiogenesis Laboratory at the University Bordeaux comprises a research group of 18 peoples. Since 1995 he raised over 15 million Euros in funding. Over that period the research has involved the supervision of 5 post-doctoral fellows and 24 graduate or undergraduate students. He is involved in teaching and training activities at the University Bordeaux, inch. a graduate course on Cancer, Angiogenesis and Tumor invasion. He is also actively involved in the organization of the Canceropoles in France ("Canceropôle du Grand Sud-Ouest"), and is the member of various committees that include the National Committee of the French Cancer Society ("Association de la Recherche sur le Cancer") and the Scientific Council of the Biology department of the University Bordeaux I.
Since 1999, I have also organized annual international angiogenesis conferences with the European School of Hematology and The European Commission has renewed his support for a further four conferences (2004-2008 inclusive).
He is presently a member of the steering committee of the integrated European project (6th Framework Program) entitled "Selective targeting of angiogenesis and the tumor stroma (STROMA)" associating 17 partners that has been recently funded by the EU. Furthermore, he is the co-ordinator of the Marie-Curie Training network STROMANET, which associates 17 partners and which is currently submitted to the European Commission.

Author and co-author of a number of papers published among others in JBC, Blood, Angiogenesis, Cancer. Res., Semin. Thromb. Hemost.

 

 

Prof. Bernd R. Binder

• born in Vienna in 1945
• 1969 Graduated from Medical School, University of Vienna
• 1973 Docent for Physiology, Medical School, University of Vienna
• 1977-1978 Visiting Lecturer on Medicine at the Harvard Medical School, Boston, USA
• 1982 Professor of Physiology, Medical School, University of Vienna
• 1985-1986 Visiting Investigator, Scripps Clinic and Research Foundation, La Jolla, CA., USA
• 1989 Docent for Clinical Chemistry and Laboratory Medicine, University of Vienna Professional Appointments
• 1969-1973 Post doctoral fellow at the Department of Medical Physiology at the University of Vienna
• 1973-1977 Head, Laboratory for Pathophysiology, Department of Physiology, University of Vienna
• 1978-1996 Head, Division of Clinical-Experimental Physiology (since 1982 a Member Laboratory of the European Thrombosis Research Organization) at the Department of Medical Physiology University of Vienna
• 1981-1987 Director for Research and Development, Serotherapeutisches Institute, Vienna
• 1981-1984 Acting Chairman, Department of Medical Physiology, University of Vienna
• 1987-present Director TECHNOCLONE GmbH. Vienna
• 1996 Appointed Head and Chairman Department of Physiology UAE University in Al Ain
• 1996-present Founding Chairman, Department of Vascular Biology and Thrombosis Research, University of Vienna
• 2000-present Director Bio-Molecular Therapeutics GmbH. Vienna (k-plus program)

Fields of research
Biochemistry, molecular and cell biology and clinical diagnosis of physiological and pathological functions of the vascular system, the blood clotting and the fibrinolytic systems. Pathologies such as atherosclerosis, tumor invasion and metastasis

Patents
11 national and international patents

Publications
4 books, 248 original and 12 review publications in peer reviewed journals inch. Nature, PNAS, FASEB J., JEM, JCI, Circulation, Circulation Research, Blood, JBC, JI, ATVB

 

 

Prof. Aldona Dembińska-Kieć

• born in Cracow, Poland in 1944
• 1969 graduated in medicine (CMUJ-Kraków) and received 3-years doctorate fellowship at the Dept. of Pharmacology (CMUJ-Kraków), 3-months training the Dept. of Pharmacology, Royal College of Surgeons in London; trained at Prof. J.R. Vane's Laboratory in Bioassay of autacoids in blood
  
• 1971 Doctor's degree at N. Copernicus Academy of Medicine in Cracow. (CMUJ Kraków), 1st degree specialist in dermatology, 18 months of Alexander von Humboldt 's fellowship. Institut of Pharmacology of the Academy of Medicine in Hannover, Germany
  
• 1979-1987 Assistant Professor in the Clinical Division of the Department of Pharmacology of N.Copernicus Academy of Medicine in Cracow
  
• 1980 Qualified for associate professorship with the thesis: Disturbance of arachidonic acid metabolism in experimental atherosclerosis, 1st degree specialisation in internal medicine, Associate Professor in the Department of Pharmacology of Nicolaus Copernicus Academy of Medicine in Cracow (CMUJ) and 6-moths fellowship in Department of Nuclear Medicine.University of Vienna (Austria)
  
• 1991-1993 Deputy Rector of Nicolaus Copernicus University School of Medicine in Cracow (CMUJ)
  
• 1992 Professorship, The specialisation in Clinical Pharmacology
  
• 1992-present Head of the Department of Clinical Biochemistry CMUJ Kraków

Professor Dembinska-Kiec is the author of 3 books, 30 chapters in books, and about 250 original articles, reviews or commentaries published among others in Am. Heart. J., ATVB, Am. J. Kidney Dis., CCA, Ann. NY Acad. Sci., Br. J. Pharmaco., Eur. J. Clin. Invest., J. Vacs. Res., Adv. Prostaglandin Thromboxane Leuko. Res.